PT  - JOURNAL ARTICLE
AU  - Shoji Okuda
AU  - Hironori Nishibori
AU  - Hiroaki Hoshi
TI  - Utility of <sup>111</sup>In-Cl<sub>3</sub> scintigraphy for differentiating bone marrow reconversion
AID  - 10.2967/jnmt.117.197913
DP  - 2017 Nov 01
TA  - Journal of Nuclear Medicine Technology
PG  - jnmt.117.197913
4099  - http://tech.snmjournals.org/content/early/2017/11/08/jnmt.117.197913.short
4100  - http://tech.snmjournals.org/content/early/2017/11/08/jnmt.117.197913.full
AB  - Indium chloride (111In-Cl3) scintigraphy has been used to evaluate various hematological diseases for many years. However, there have been few reports on patients with bone marrow reconversion showing high uptake in 111In-Cl3 scintigraphy. Herein, we report a case of a 68-year-old man with esophageal cancer who underwent 18F-FDG PET/CT for staging of the disease. 18F-FDG PET/CT demonstrated high uptake in the first lumbar vertebral body, which was difficult to distinguish bone metastasis and bone marrow reconversion. 111In-Cl3 scintigraphy demonstrated specific findings with high uptake in the lesion, indicating bone marrow hyperplasia or reconversion.